About GDNF family receptor alpha-like
GDNF family receptor alpha-like (GFRAL) is a protein
from Homo sapiens identified by UniProt accession
Q6UXV0, 394 residues long.
MolForge cross-references it against 0 known binders and
65 disease associations.
Target properties
| Protein name | GDNF family receptor alpha-like |
| UniProt accession | Q6UXV0 |
| Gene | GFRAL |
| Organism | Homo sapiens |
| Length | 394 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (65)
Diseases linked to this target (Open Targets).
- heel bone mineral density · score 0.48
- blood protein measurement · score 0.43
- chronotype measurement · score 0.41
- body mass index · score 0.40
- arterial stiffness measurement · score 0.30
- daytime rest measurement · score 0.19
- high density lipoprotein cholesterol measurement · score 0.16
- nausea and vomiting of pregnancy severity measurement · score 0.13
- circadian rhythm · score 0.07
- excessive daytime sleepiness measurement · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6UXV0-F1 | alphafold | PREDICTED | 76.83 | — |
Amino-acid sequence (394 residues)
MIVFIFLAMG LSLENEYTSQ TNNCTYLREQ CLRDANGCKH AWRVMEDACN DSDPGDPCKM RNSSYCNLSI QYLVESNFQF KECLCTDDFY CTVNKLLGKK CINKSDNVKE DKFKWNLTTR SHHGFKGMWS CLEVAEACVG DVVCNAQLAS YLKACSANGN PCDLKQCQAA IRFFYQNIPF NIAQMLAFCD CAQSDIPCQQ SKEALHSKTC AVNMVPPPTC LSVIRSCQND ELCRRHYRTF QSKCWQRVTR KCHEDENCIS TLSKQDLTCS GSDDCKAAYI DILGTVLQVQ CTCRTITQSE ESLCKIFQHM LHRKSCFNYP TLSNVKGMAL YTRKHANKIT LTGFHSPFNG EVIYAAMCMT VTCGILLLVM VKLRTSRISS KARDPSSIQI PGEL
Explore GDNF family receptor alpha-like with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets